Literature DB >> 14550891

Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man.

John B Dame1, Charles A Yowell, Levi Omara-Opyene, Jane M Carlton, Roland A Cooper, Tang Li.   

Abstract

Plasmepsins are aspartic proteinases of the malaria parasite, and seven groups of plasmepsins have been identified by comparing genomic sequence data available for the genes encoding these enzymes from Plasmodium falciparum, Plasmodium vivax, Plasmodium knowlesi, Plasmodium berghei, and Plasmodium yoelii. The food vacuole plasmepsins typified by plasmepsin 4 from P. falciparum (PfPM4) constitute one of these groups. Genes encoding the ortholog of PfPM4 have been cloned from Plasmodium ovale, Plasmodium malariae, and P. vivax. In addition, P. falciparum contains three paralagous food vacuole plasmepsins or plasmepsin-like enzymes that appear to have arisen by gene duplication, plasmepsins 1 (PfPM1), 2 (PfPM2) and HAP, and all four were localized to purified food vacuole preparations by two-dimensional gel electrophoresis and mass spectroscopic analysis. The three paralogs of PfPM4 do not have counterparts in the six other Plasmodium spp. examined by genomic DNA blot analysis and by review of available genomic sequence data. The presence of these paralogs among the food vacuole plasmepsins in P. falciparum as compared with the other three species causing malaria in man will impact efforts to rationally design antimalarials targeting the food vacuole plasmepsins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550891     DOI: 10.1016/s0166-6851(03)00137-3

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  23 in total

1.  Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria.

Authors:  Katherine T Andrews; David P Fairlie; Praveen K Madala; John Ray; David M Wyatt; Petrina M Hilton; Lewis A Melville; Lynette Beattie; Donald L Gardiner; Robert C Reid; Martin J Stoermer; Tina Skinner-Adams; Colin Berry; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Rodent and nonrodent malaria parasites differ in their phospholipid metabolic pathways.

Authors:  Sandrine Déchamps; Marjorie Maynadier; Sharon Wein; Laila Gannoun-Zaki; Eric Maréchal; Henri J Vial
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 3.  Malaria parasite plasmepsins: More than just plain old degradative pepsins.

Authors:  Armiyaw S Nasamu; Alexander J Polino; Eva S Istvan; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2020-05-04       Impact factor: 5.157

Review 4.  Sequence, Structural Analysis and Metrics to Define the Unique Dynamic Features of the Flap Regions Among Aspartic Proteases.

Authors:  Lara McGillewie; Muthusamy Ramesh; Mahmoud E Soliman
Journal:  Protein J       Date:  2017-10       Impact factor: 2.371

5.  Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Authors:  Roberta Spaccapelo; Chris J Janse; Sara Caterbi; Blandine Franke-Fayard; J Alfredo Bonilla; Luke M Syphard; Manlio Di Cristina; Tania Dottorini; Andrea Savarino; Antonio Cassone; Francesco Bistoni; Andrew P Waters; John B Dame; Andrea Crisanti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

6.  Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.

Authors:  Fengwu Li; Kailash P Patra; Charles A Yowell; John B Dame; Karen Chin; Joseph M Vinetz
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

7.  Biochemical properties of a novel cysteine protease of Plasmodium vivax, vivapain-4.

Authors:  Byoung-Kuk Na; Young-An Bae; Young-Gun Zo; Youngchool Choe; Seon-Hee Kim; Prashant V Desai; Mitchell A Avery; Charles S Craik; Tong-Soo Kim; Philip J Rosenthal; Yoon Kong
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

8.  Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.

Authors:  Peng Liu; Melissa R Marzahn; Arthur H Robbins; Hugo Gutiérrez-de-Terán; David Rodríguez; Scott H McClung; Stanley M Stevens; Charles A Yowell; John B Dame; Robert McKenna; Ben M Dunn
Journal:  Biochemistry       Date:  2009-05-19       Impact factor: 3.162

9.  Analysis of binding interactions of pepsin inhibitor-3 to mammalian and malarial aspartic proteases.

Authors:  Rebecca E Moose; José C Clemente; Larry R Jackson; Minh Ngo; Kimberly Wooten; Richard Chang; Antonette Bennett; Sibani Chakraborty; Charles A Yowell; John B Dame; Mavis Agbandje-McKenna; Ben M Dunn
Journal:  Biochemistry       Date:  2007-11-16       Impact factor: 3.162

10.  Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.

Authors:  U Lek-Uthai; R Suwanarusk; R Ruengweerayut; T S Skinner-Adams; F Nosten; D L Gardiner; P Boonma; K A Piera; K T Andrews; B Machunter; J S McCarthy; N M Anstey; R N Price; B Russell
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.